Clinical Trial

Adherence to the Mediterranean Diet Among Women Attending Mammographic Screening

Study acronym: PREVCAR
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 12, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The PREVCAR study is a cross-sectional investigation aimed at evaluating dietary habits among women undergoing breast cancer screening. Specifically, the study focuses on adherence to the Mediterranean diet, a dietary pattern recognized for its potential protective role against chronic diseases, including breast cancer. The PREVCAR study will include approximately 35,000 women aged 18 and older who participate in the "Prevention Caravan" and complete both the breast cancer screening and the MEDAS (Mediterranean Diet Adherence Screener) questionnaire. This 14-item questionnaire measures dietary behavior, with scores reflecting levels of adherence to the Mediterranean diet. The primary objective of the study is to determine the average MEDAS score among participants. Secondary objectives include analyzing how adherence varies across different known breast cancer risk factors-such as age, menopausal status, hormonal therapy use, and reproductive history-and assessing the prevalence of malignant breast lesions identified through the screening.
Trial Details
NCT Number NCT07016711
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Breast Cancer Prevention
Enrollment 35,000 participants
Start Date 2025-06
Primary Completion 2026-05 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2025-06-12